Back to Agenda
Session 7B: Pharmacovigilance (Parallel Sessions 1)
Session Chair(s)
Reem K Al Essa, MBA
Coordination & Development Superintendent Pharmaceutical Services Administration
Ministry of Health, Kuwait
Hadir Rostom
Head, Egyptian Pharmaceutical Vigilance Center (EPVC)
Pharmaceutical Affairs Central Administration (CAPA), Ministry of Health, Egypt, Egypt
Session 7B: Pharmacovigilance (Parallel Sessions 1)
Speaker(s)
Smart Safety Surveillance for priority medical products
Shanthi Pal, DrSc, MPharm
WHO, Switzerland
Group Lead, Medicines Safety, Safety & Vigilance
The SFDA Experience – Moving to the Investigation Phase
Mohammed Ebrahim Fouda, PharmD, RPh
SFDA, Saudi Arabia
Head of Signal Detection Department
Kuwait’s Roadmap on Pharmacovigilance
Reem K Al Essa, MBA
Ministry of Health, Kuwait
Coordination & Development Superintendent Pharmaceutical Services Administration
Q&A and Panel Discussion, with the participation of:
Phil Tregunno
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Deputy Director - Patient Safety Monitoring
Sean Burke, MSc
Merck , United Kingdom
Pharmacovigilance Lead, EEMEA
Have an account?